top of page

Currently ongoing clinical trials of PVX108  for Peanut Allergy

Examination of a child
Phase 2 Studies: AVX-201
(currently recruiting)

​

AVX-201 is a double blind randomised Phase 2 study in adolescents and children with peanut allergy. The aims of the trial are to evaluate the efficacy and safety of PVX108 when administered intradermally in monthly doses over a 12 month period. The AVX-201 trial is being run under an IND and is currently recruiting at clinics in Australia and the United States.

Interested in participating?
Find out more on ClinicalTrials.gov or contact the trial centre nearest you (details below)

Australia

New South Wales

Enrolling by invitation

​Children's Hospital at Westmead

Westmead, NSW 2145 

SCHN-CHW-AllergyResearch@health.nsw.gov.au
 

Enrolling by invitation

Sydney Children's Hospital

Randwick, NSW 2031

SCHN-SCHClinicalTrials@health.nsw.gov.au

Queensland

Enrolling by invitation

​

Queensland Children's Hospital

South Brisbane, QLD 4101

qpias-research@health.qld.gov.au

South Australia

Enrolling by invitation

​

Women's and Children's Hospital, Adelaide

North Adelaide, SA 5006

health.wchnallergyresearch@sa.gov.au

Victoria

Enrolling by invitation


Murdoch Children's Research Institute,

Royal Children's Hospital

Melbourne Parkville, VIC 3052

aravax.peanut@mcri.edu.au

United States

Arkansas

Enrolling by invitation

​

Arkansas Children's Research Institute
Little Rock, Arkansas,
 72202

NorrisKD@archildrens.org

California

Enrolling by invitation


Peninsula Research Associates

Rolling Hills Estates, California, 90274

dominic.venardi@peninsularesearch.com

Georgia

Enrolling by invitation

​

Children's Healthcare of Atlanta

Atlanta, Georgia, 30329

jessica.stafford@choa.org

Maryland

Enrolling by invitation

​

IAA Clinical Research

Chevy Chase, Maryland, 20815

iaaresearchwan@gmail.com

Massachusetts

Enrolling by invitation

​

Massachusetts General Hospital

Boston, Massachusetts, 02114

takhtar@mgh.harvard.edu

Indiana

Enrolling by invitation

​

Riley Children's Hospital at IU

Indianapolis, Indiana, 462020

ptc@iu.edu

Maryland

Enrolling by invitation

​

Johns Hopkins Hospital

Baltimore, Maryland, 21205

mhairst4@jh.edu

North Carolina

Enrolling by invitation

​

University of North Carolina at Chapel Hill

Chapel Hill, North Carolina, 27599

foodallergy@unc.edu

Western Australia

Enrolling by invitation

​

Perth Children's Hospital

Nedlands, WA 6009

foodallergyresearch@health.wa.gov.au

bottom of page